Lixisenatide (AVE0010)
EFC6014
Approved small_molecule completed
Quick answer
Lixisenatide (AVE0010) for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at Sanofi Pasteur with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed